advertisement
11.4 Prostaglandins (22)
Showing records 1 to 22
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins9704 Latanoprost stimulates secretion of matrix metalloproteinases in tenon fibroblasts both in vitro and in vivo
Mietz H; Esser JM; Welsandt G; Kociok N; Hueber A; Joussen A; Esser P; Krieglstein GK
Investigative Ophthalmology and Visual Science 2003; 44: 5182-5188
9726 Latanoprost in port wine stain related paediatric glaucoma
Ong T; Chia A; Nischal KK
British Journal of Ophthalmology 2003; 87: 1091-1093
10040 A short-term study of the additive effect of latanoprost 0.005% and brimonidine 0.2%
Erdoğan H; Toker İ; Kemal Arıcı M; Aygen A; Topalkara A
Japanese Journal of Ophthalmology 2003; 47: 473-478
9899 Rate of response to latanoprost or timolol in patients with ocular hypertension or glaucoma
Camras CB; Hedman K; US Latanoprost Study Group
Journal of Glaucoma 2003; 12: 466-469
9900 A three-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension
Coleman AL; Lerner F; Bernstein P; Whitcup SM; Lumigan/Cosopt Study Group
Ophthalmology 2003; 110: 2362-2368
9904 Assessing the cost-effectiveness of switching from a β-blocker to latanoprost in the treatment of ocular hypertension
Costagliola C; Parmeggiani F; Sebastiani A
Expert Opinion in Pharmacotherapy 2003; 4: 1775-1788
9903 Estimating the long-term visual field consequences of average daily intraocular pressure and variance: A clinical trial comparing timolol, latanoprost and travoprost
Nordmann JP; LePen C; Lilliu H; Berdeaux G
Clinical Drug Investigation 2003; 23: 431-438
10041 Additive effect of bunazosin on intraocular pressure when topically added to treatment with latanoprost in patients with glaucoma
Tsukamoto H; Jian K; Tajamatsu M; Okada K; Mukai S; Tsumamoto Y; Mishima HK
Japanese Journal of Ophthalmology 2003; 47: 526-528
9917 Effects of travoprost eye drops on intraocular pressure and pulsatile ocular blood flow: a 180-day, randomized, double-masked comparison with latanoprost eye drops in patients with open-angle glaucoma
Cardascia N; Vetrugno M; Trabucco T; Cantatore F; Sborgia C
Current Therapeutic Research - Clinical and Experimental 2003; 64: 389-400
9921 Latanoprost-induced iris darkening: a morphometric study of human peripheral iridectomies
Cracknell KPB; Grierson I; Hogg P; Appleton P; Pfeiffer N
Experimental Eye Research 2003; 77: 721-730
9923 Projected impact of travoprost versus both timolol and latanoprost on visual field deficit progression and costs among black glaucoma subjects
Halpern MT; Covert DW; Robin AL; Shields MB; Flach AJ; Stamper RL
Transactions of the American Ophthalmological Society 2002; 100: 109-118
9913 Pooled-data analysis of three randomized, double-masked, six-month studies comparing intraocular pressure-reducing effects of latanoprost and timolol in patients with ocular hypertension
Hedman K; Alm A; Gross RL
Journal of Glaucoma 2003; 12: 463-465
9924 Effect of latanoprost on diurnal variations of intraocular pressure in normal-tension glaucoma
Nakamoto K; Yasuda N; Nanno M; Kinohira Y; Murai K; Fukuda T
Nippon Ganka Gakkai Zasshi 2003; 107: 530-534
9926 Response to travoprost in black and nonblack patients with open-angle glaucoma or ocular hypertension
Netland PA; Robertson SM; Sullivan EK; Silver L; Bergamini MV; Krueger S; Weiner AL; Davis AA
Advances in Therapy 2003; 20: 149-163
9911 Bilateral nongranulomatous anterior uveitis associated with bimatoprost
Packer M; Fine H; Hoffman RS
Journal of Cataract and Refractive Surgery 2003; 29: 2242-2243
9910 Intraocular pressure after replacement of current dual therapy with latanoprost monotherapy in patients with open angle glaucoma
Pillunat LE; Larsson LI
British Journal of Ophthalmology 2003; 87: 1492-1496
9925 Ocular hypotensive effects of melatonin receptor agonists in the rabbit: further evidence for an MT3 receptor
Pintor J; Pelaez T; Hoyle CH; Peral A
British Journal of Pharmacology 2003; 138: 831-836
9915 Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide
Richter M; Krauss AH; Woodward DF; Lutjen Drecoll E
Investigative Ophthalmology and Visual Science 2003; 44: 4419-4426
9919 Human ciliary muscle cell responses to FP-class prostaglandin analogues: phosphoinositide hydrolysis, intracellular Ca2+ mobilization and MAP kinase activation
Sharif NA; Crider JY; Husain S; Kaddour Djebbar I; Ansari HR; Abdel Latif AA
Journal of Ocular Pharmacology and Therapeutics 2003; 19: 437-455
9912 Corneal punctate staining with latanoprost, bimatoprost, and travoprost in healthy subjects
Stewart WC; Stewart JA; Jenkins JN; Jackson AL
Journal of Glaucoma 2003; 12: 475-479
9920 Intraocular pressure, safety, and quality of life in glaucoma patients switching to latanoprost from monotherapy treatments
Zimmerman TJ; Stewart WC
Journal of Ocular Pharmacology and Therapeutics 2003; 19: 405-415
9885 Evaluation of retinal haemodynamics and retinal function after application of dorzolamide, timolol and latanoprost in newly diagnosed open-angle glaucoma patients
Arend O; Harris A; Wolter P; Remky A
Acta Ophthalmologica Scandinavica 2003; 81: 474-479
